FDA Issues Warning Letters to CBD Manufacturers Making “Over-The-Line” Health Claims
Canna Law Blog
APRIL 13, 2019
Last week, the departing Food and Drug Administration (“FDA”) Commissioner, Scott Gottlieb, released a statement in which he announced that the agency, in collaboration with the Federal Trade Commission (“FTC”), had issued warning letters to three CBD manufacturers: Advanced Spine and Pain LLC (d/b/a Relievus) , Nutra Pure LLC and PotNetwork Holdings Inc.
Let's personalize your content